Cell and Gene Outsourcing

  1. Candidate Screening And Feasibility Studies For Viral Gene Therapies

    Create a simple, modular path to cGMP manufacturing that minimizes risk. Explore a strategic approach for early-stage development and how it can propel therapies to the clinic and the market.

  2. Selecting Containers For Sensitive And Costly Cell & Gene Therapies

    Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.

  3. Cell & Gene Therapy Development: Characterization Of Cellular Starting Material 6/21/2024

    Watch to gain valuable insights into the characterization of cellular source material for the development and manufacture of cell and gene therapy-based products.

  4. The CDMO Value Proposition For Your Autologous Cell Therapy

    This panel session features a decade-long story of partnership in bringing two life-changing gene therapies to market successfully in 2022.

  5. Critical Supply Chain And Logistics Considerations For Cell And Gene Therapy Management 8/30/2024

    Explore the unique challenges and complexities involved in key CGT logistics areas like donor and patient accessibility, critical raw materials management, and innovative temperature control equipment.

  6. WuXi Advanced Therapies Philadelphia Campus Overview 5/20/2024

    Our Philadelphia Campus serves as a centralized hub for collaborative efforts, supporting numerous companies throughout the CGT pipeline, from initial research to commercial-scale manufacturing.

  7. Identify And Quantify AAV Fill States Using Analytical Ultracentrifugation 3/14/2024

    Explore how to implement analysis using sedimentation velocity analytical ultracentrifugation to characterize AAV size distributions and multiple detection wavelengths to identify various fill states in AAV preparation.

  8. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  9. CRISPR Genome Editing Solutions From Discovery To Clinic

    Examine how a partnership leveraging expertise in production for high-quality CRISPR gRNAs as well as cGMP manufacturing is supporting the clinical translation of CRISPR genome editing technologies.

  10. A Robust And Scalable Suspension Platform For AAV Manufacturing

    Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.